According to FutureWise analysis, the precision medicine market in 2026 is US$46 billion, and is expected to reach US$ 150 billion by 2036 at a CAGR of 13.5%.
This growth is primarily driven by the increasing adoption of genomics and advanced diagnostic technologies, enabling more personalized and targeted treatment approaches. The integration of artificial intelligence and big data analytics is further accelerating drug discovery and improving clinical decision-making. Rising prevalence of chronic diseases such as cancer and cardiovascular conditions is also fueling demand for precision-based therapies. Additionally, growing investments from both public and private sectors are supporting research and development in this field. Expanding healthcare infrastructure in emerging economies is contributing to wider accessibility of precision medicine solutions. Regulatory support and advancements in biomarker identification are expected to further strengthen market expansion over the forecast period.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Precision Medicine Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of the market.
According to the research study conducted by FutureWise research analysts, the Precision Medicine Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.